Here are four highlights:
1. RETeval Complete is one of the first non-mydriatic, noninvasive hand-held, full function ISCEV protocol-compliant visual electrophysiology device performing both flash Electroetinogram and flash visual evoked potential testing using skin or corneal electrodes.
2. The patented device is FDA-cleared, CE-marked and currently approved for use in 73 countries around the world.
3. The RETeval is especially helpful in young children with nystagmus and a normal fundus, who may have Leber’s congenital amaurosis, congenital stationary night blindness or achromatopsia.
4. LKC Technologies will exhibit the RETeval Complete at the American Association of Pediatric Ophthalmology annual meeting in Vancouver in Canada from April 6 to April 10.
More articles on healthcare:
Practicing engaged medicine at ASCs — How videotaping surgery promotes transparency & patient engagement
7 things for ASC leaders to know for Monday — March 28, 2016
5 things to know about telehealth technology Health Navigator
